BioCryst Pharmaceuticals Current Ratio 2006-2018 | BCRX

BioCryst Pharmaceuticals current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
BioCryst Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.11B $0.07B 1.65
2018-09-30 $0.13B $0.06B 2.00
2018-06-30 $0.09B $0.07B 1.25
2018-03-31 $0.10B $0.08B 1.38
2017-12-31 $0.13B $0.08B 1.68
2017-09-30 $0.18B $0.07B 2.53
2017-06-30 $0.09B $0.06B 1.57
2017-03-31 $0.11B $0.06B 1.94
2016-12-31 $0.07B $0.05B 1.23
2016-09-30 $0.07B $0.05B 1.26
2016-06-30 $0.05B $0.06B 0.82
2016-03-31 $0.05B $0.06B 0.80
2015-12-31 $0.06B $0.06B 1.03
2015-09-30 $0.09B $0.06B 1.31
2015-06-30 $0.11B $0.06B 1.68
2015-03-31 $0.08B $0.06B 1.32
2014-12-31 $0.09B $0.06B 1.56
2014-09-30 $0.14B $0.05B 2.71
2014-06-30 $0.14B $0.05B 3.08
2014-03-31 $0.04B $0.01B 2.61
2013-12-31 $0.04B $0.02B 2.76
2013-09-30 $0.05B $0.01B 3.55
2013-06-30 $0.03B $0.01B 2.80
2013-03-31 $0.04B $0.01B 3.13
2012-12-31 $0.04B $0.02B 2.44
2012-09-30 $0.05B $0.01B 3.71
2012-06-30 $0.05B $0.02B 2.36
2012-03-31 $0.05B $0.02B 3.28
2011-12-31 $0.05B $0.03B 2.01
2011-09-30 $0.06B $0.02B 3.13
2011-06-30 $0.08B $0.02B 3.64
2011-03-31 $0.10B $0.02B 4.61
2010-12-31 $0.09B $0.03B 3.12
2010-09-30 $0.09B $0.02B 4.43
2010-06-30 $0.08B $0.02B 5.28
2010-03-31 $0.09B $0.02B 4.40
2009-12-31 $0.11B $0.04B 2.98
2009-09-30 $0.05B $0.02B 2.86
2009-06-30 $0.06B $0.01B 4.27
2009-03-31 $0.07B $0.01B 4.80
2008-12-31 $0.08B $0.02B 4.39
2008-09-30 $0.08B $0.02B 4.56
2008-06-30 $0.06B $0.02B 3.21
2008-03-31 $0.08B $0.03B 2.98
2007-12-31 $0.09B $0.03B 3.26
2007-09-30 $0.09B $0.03B 3.70
2007-06-30 $0.05B $0.02B 3.00
2007-03-31 $0.05B $0.01B 3.48
2006-12-31 $0.05B $0.01B 4.27
2006-09-30 $0.05B $0.01B 3.77
2006-06-30 $0.06B $0.01B 6.33
2006-03-31 $0.07B $0.01B 6.52
2005-12-31 $0.08B $0.01B 7.13
2005-09-30 $0.03B $0.00B 9.13
2005-06-30 $0.03B $0.00B 14.95
2005-03-31 $0.04B $0.00B 15.55
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.873B $0.021B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.457B 31.54
Takeda Pharmaceutical (TAK) Japan $28.357B 10.49
Grifols (GRFS) Spain $12.830B 15.68
Ionis Pharmaceuticals (IONS) United States $10.102B 32.30
Sage Therapeutics (SAGE) United States $7.758B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.328B 10.49
Neurocrine Biosciences (NBIX) United States $7.158B 461.35
Catalent (CTLT) United States $6.403B 26.81
Nektar Therapeutics (NKTR) United States $5.516B 8.80
Tilray (TLRY) United States $4.740B 0.00
United Therapeutics (UTHR) United States $4.387B 7.46
Taro Pharmaceutical Industries (TARO) Israel $4.097B 13.19
FibroGen (FGEN) United States $4.039B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.793B 0.00
Portola Pharmaceuticals (PTLA) United States $2.252B 0.00
PTC Therapeutics (PTCT) United States $2.099B 0.00
USANA Health Sciences (USNA) United States $1.921B 16.12
Heron Therapeutics (HRTX) United States $1.837B 0.00
Aerie Pharmaceuticals (AERI) United States $1.799B 0.00
Xencor (XNCR) United States $1.765B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.738B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.712B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.668B 20.77
Madrigal Pharmaceuticals (MDGL) United States $1.627B 0.00
Endo (ENDP) Ireland $1.598B 2.46
Zogenix (ZGNX) United States $1.534B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.518B 131.46
Corcept Therapeutics (CORT) United States $1.372B 19.93
Tricida (TCDA) United States $1.330B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.279B 0.00
Esperion Therapeutics (ESPR) United States $1.098B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.066B 0.00
TherapeuticsMD (TXMD) United States $1.020B 0.00
Radius Health (RDUS) United States $0.980B 0.00
Akebia Therapeutics (AKBA) United States $0.786B 0.00
CannTrust Holdings (CTST) Canada $0.751B 0.00
ArQule (ARQL) United States $0.713B 0.00
ChemoCentryx (CCXI) United States $0.700B 0.00
Dermira (DERM) United States $0.619B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.577B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Odonate Therapeutics (ODT) United States $0.573B 0.00
Forty Seven (FTSV) United States $0.559B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.546B 0.00
GlycoMimetics (GLYC) United States $0.523B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.460B 23.76
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
Translate Bio (TBIO) United States $0.452B 0.00
Collegium Pharmaceutical (COLL) United States $0.451B 0.00
KalVista Pharmaceuticals (KALV) United States $0.440B 0.00
TCR2 THERAPTCS (TCRR) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.430B 0.00
OptiNose (OPTN) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.396B 0.00
Flexion Therapeutics (FLXN) United States $0.388B 0.00
Aptorum Group (APM) China $0.388B 0.00
ImmunoGen (IMGN) United States $0.368B 0.00
Mast Therapeutics (SVRA) United States $0.334B 0.00
Harpoon Therapy (HARP) United States $0.317B 0.00
CASI Pharmaceuticals (CASI) United States $0.316B 0.00
Karyopharm Therapeutics (KPTI) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.281B 2.61
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.276B 10.21
Minerva Neurosciences (NERV) United States $0.274B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.274B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.251B 0.00
Calithera Biosciences (CALA) United States $0.241B 0.00
Dova Pharmaceuticals (DOVA) United States $0.233B 0.00
Molecular Templates (MTEM) United States $0.231B 0.00
Aclaris Therapeutics (ACRS) United States $0.228B 0.00
Concert Pharmaceuticals (CNCE) United States $0.222B 0.00
Ardelyx (ARDX) United States $0.212B 0.00
Affimed (AFMD) Germany $0.209B 0.00
MEI Pharma (MEIP) United States $0.208B 0.00
Aldeyra Therapeutics (ALDX) United States $0.204B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.201B 0.00
Opexa Therapeutics (ACER) United States $0.200B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.194B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.184B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 189.00
ElectroCore (ECOR) United States $0.182B 0.00
Neon Therapeutics (NTGN) United States $0.177B 0.00
Majesco Entertainment (PTE) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.172B 0.00
Aratana Therapeutics (PETX) United States $0.171B 0.00
IMV INC (IMV) Canada $0.170B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.168B 0.00
Tyme Technologies (TYME) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.157B 0.00
Ocular Therapeutix (OCUL) United States $0.156B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
MediWound (MDWD) Israel $0.132B 0.00
China SXT Pharmaceuticals (SXTC) China $0.119B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
ProNAi Therapeutics (SRRA) Canada $0.109B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
Nivalis Therapeutics (ALPN) United States $0.105B 0.00
Natural Alternatives (NAII) United States $0.098B 9.62
Neos Therapeutics (NEOS) United States $0.097B 0.00
Zafgen (ZFGN) United States $0.097B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.094B 0.00
Adherex Technologies (FENC) United States $0.094B 0.00
DURECT (DRRX) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.092B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.090B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.083B 0.00
SCYNEXIS (SCYX) United States $0.083B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Capnia (SLNO) United States $0.064B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.049B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Bio-Path Holdings (BPTH) United States $0.048B 0.00
Lipocine (LPCN) United States $0.044B 0.00
KemPharm (KMPH) United States $0.043B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.043B 0.00
ContraFect (CFRX) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Shineco (TYHT) China $0.029B 4.88
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.47
PharmAthene (ALT) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
NOVAN INC (NOVN) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 4.07
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Achaogen (AKAO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00